NFASC and metabolic disease: Interestingly, antagonistic crosstalk between Nf-kb and Sirt1 in the regulation of inflammation and metabolic disorders have been reported, with Sirt1 inhibition capable of disrupting oxidative energy metabolism and stimulating the Nf-kb-induced inflammatory responses that characterise several age-related and chronic metabolic diseases [61].